Transforming Proteomic Data Analysis with Artificial Intelligence
MSAID provides cutting-edge software & data analysis services for proteomics using powerful machine learning algorithms.
Almost all diseases manifest as changes of the expression, abundance or signaling status of proteins. Therefore, the precise analysis of the proteome (the entirety of a biological system’s proteins) is a crucial step in the understanding, diagnosis, and treatment of diseases. Mass spectrometry-based proteomics is a powerful technique for the simultaneous analysis of thousands of proteins, fueling biomarker research and drug discovery. However, while technological and methodological advances have propelled proteome research forward, data analysis often relies on simple concepts that remained unchanged for decades – a challenge MSAID aims to resolve.
The MSAID GmbH is a privately held informatics spin-off from the Technical University of Munich, Germany. It was founded by an interdisciplinary team of scientists with the vision to provide better computational solutions to the field of proteomics. The company’s approach is to replace current algorithms for proteomics with powerful, AI-based solutions, thereby paving the way for a smarter, deeper, and more reliable way of interrogating proteomic data.
Kontakt: info [at] msaid.de
Telefon: +49 (0) 89 215 366 18
Ansprechpartner: Dr. Martin Frejno